Botulinum Toxin Treatment in Singapore
Doctor-led botulinum toxin type A treatment for selected dynamic facial lines and muscle-related contour concerns. Treatment is planned around anatomy, muscle strength, facial balance and the individual product used.
The goal is controlled reduction of selected muscle activity — not a frozen face and not blanket treatment of every wrinkle.
Two distinctions do most of the work at consultation. The first is whether a line is dynamic, appearing on movement, or static, visible at rest — because toxin addresses the first far better than the second. The second is whether what you dislike is a line at all, or a change in volume, skin quality or tissue position that toxin will not touch.
Botulinum toxin at a glance
| What it is | A purified protein that temporarily reduces nerve signalling to a treated muscle, decreasing its contraction |
|---|---|
| Best suited to | Dynamic lines driven by repeated expression, and selected muscle bulk such as genuine masseter hypertrophy |
| Not suited to | Static etched lines, volume loss, skin laxity, pigmentation, or a broad lower face caused by bone or fat |
| Onset | Not immediate. Effect typically becomes noticeable over several days, with full effect assessed around two weeks |
| Review point | Around two weeks, when any adjustment for asymmetry is best made |
| Duration | Variable by product, dose, muscle and individual. Large muscles such as the masseter behave differently from small upper-face muscles |
| Anaesthesia | Usually none. Very fine needles are used and treatment takes minutes |
| Downtime | Minimal. Small raised bumps settle within an hour; pinpoint bruising is possible |
| Key caution | Dose units are product-specific and never interchangeable between formulations |
| Where | Aquila Medical Center, 160 Robinson Road, #05-01 SBF Centre Medical Suites, Singapore 068914 |
How botulinum toxin works
Botulinum toxin type A temporarily reduces acetylcholine release at the neuromuscular junction, decreasing contraction in the treated muscle. In aesthetic practice this can soften lines caused mainly by repeated expression or reduce the bulk of selected muscles when that bulk contributes to facial or body contour.
The effect is temporary by design. Nerve terminals gradually regenerate their connections over the following months, which is why activity returns and why treatment is repeated rather than being permanent. Nothing is being paralysed irreversibly, and nothing accumulates in the body between sessions.
Understanding this also explains the difference between softening a line and reducing a muscle. Upper-face treatment works quickly because you are reducing the folding of skin. Masseter treatment works slowly because you are waiting for an under-used muscle to lose bulk, which takes weeks to months rather than days.
Units are product-specific. Dose units are not interchangeable across different botulinum toxin formulations. A numerical dose from one product should not be copied directly to another.
This matters commercially as well as clinically. Clinics quoting a low price per unit may be using a product whose units are not equivalent to another's, so comparing prices per unit across clinics is meaningless without knowing which product is being used. The right question is which product, and what total dose for the area.
Dynamic facial lines
Selected forehead, glabellar and lateral canthal lines may improve when muscle activity is the main driver.
Masseter contouring
For genuine masseter hypertrophy, treatment can reduce muscle prominence over time. It does not reduce jaw bone width or every cause of a broad lower face.
Selected body muscles
Some practices use toxin for muscular trapezius or calf prominence. These are anatomy-dependent applications and require careful assessment of function as well as appearance.
Bruxism and jaw tension
Many patients seeking masseter treatment also clench or grind. Where symptoms are present this is worth raising, since it changes how success is defined.
Hyperhidrosis
Reducing acetylcholine signalling also affects sweat glands, which is the basis for treating excessive underarm or palmar sweating — a medical rather than purely cosmetic use.
Prevention claims
Reducing repeated creasing may slow the etching of dynamic lines over years, but toxin does not prevent ageing, photodamage or skin-quality decline.
What can be considered?
| Concern | Possible role | Important limitation |
|---|---|---|
| Frown lines | Reduce activity of selected glabellar muscles. | Static etched lines may not disappear completely. |
| Forehead lines | Reduce selected frontalis activity. | Over-treatment can lower brow position or feel heavy in susceptible patients. |
| Crow's feet | Reduce selected lateral orbicularis activity. | Fine lines from photodamage or skin quality may need complementary treatment. |
| Masseter hypertrophy | Reduce muscle thickness/prominence over time. | Not a treatment for mandibular bone width, jowls or submental fat. |
| Chin / lower-face muscle activity | Selected mentalis or depressor patterns may be treated. | Lower-face injections can affect smile mechanics if diffusion or placement is inappropriate. |
| Gummy smile | Selected patterns of excessive upper-lip elevation may be softened. | Small doses and precise placement; over-treatment produces an asymmetric or flattened smile. |
| Excessive sweating | Underarm and palmar hyperhidrosis is an established use. | A medical indication with its own dosing; discuss it as such rather than as a cosmetic add-on. |
| Trapezius / calf prominence | Selected muscular contour concerns may be considered. | These muscles have functional roles; treatment should not be based on appearance alone. |
Where a line is deeply etched at rest, toxin softens the movement that maintains it but may not erase the crease itself. In those cases a combined approach — reducing the muscle activity, then addressing the line separately — is usually more honest than promising toxin alone will clear it.
Masseter treatment is not the same as jawline slimming
A wide lower face can result from masseter hypertrophy, mandibular skeletal width, parotid prominence, subcutaneous fat, jowling or combinations of these. Botulinum toxin can only reduce the muscular component.
A simple test at consultation is to clench the teeth and watch whether the width visibly increases. If it does, muscle is contributing and treatment may help. If the width is unchanged on clenching, the mandible itself is more likely responsible, and toxin will achieve little regardless of dose.
Systematic reviews support a reduction in masseter prominence in appropriately selected patients, but published studies use different products, doses and outcome measures. This means there is no single universal dose or treatment interval that should be applied to every patient.
Timing expectations differ from upper-face treatment. Muscle activity reduces within a couple of weeks, but visible narrowing develops as bulk decreases, commonly over one to three months. Judging masseter treatment at three weeks reliably produces a falsely disappointed conclusion.
Assessment should also consider chewing strength, bruxism symptoms, facial asymmetry and the possibility that excessive masseter reduction may unmask or accentuate lower-face laxity in some patients. Over years, sustained reduction in an already slim face can contribute to a hollow lower cheek, which is a reason to review the plan periodically rather than repeat it automatically.
When will it work and how long will it last?
Botulinum toxin does not work instantly. Early reduction in muscle activity usually becomes noticeable over several days, with the full clinical effect assessed later. Duration varies by product, dose, muscle, treatment area, individual physiology and repeated treatment history.
A practical rhythm is: nothing for the first two or three days, gradual softening through the first week, full effect by around two weeks. Two weeks is therefore the point at which the result should be judged and any small asymmetry adjusted — not day four, when partial onset frequently looks uneven and prompts unnecessary worry.
Aquila does not promise one fixed duration for every indication. Large powerful muscles such as the masseter may have a different clinical course from smaller upper-face muscles, and contour change from muscle thinning develops differently from wrinkle softening.
A small proportion of patients respond less well than expected, and rarely this reflects neutralising antibodies developing after repeated treatment. Very frequent treatment and high cumulative doses are thought to increase that risk, which is one argument against topping up more often than genuinely needed.
Risks and side effects
Common temporary effects include injection-site discomfort, bruising, headache, tenderness and asymmetry during the settling period. Depending on injection area, unwanted weakening of adjacent muscles can cause brow or eyelid ptosis, altered smile, chewing fatigue, neck weakness or other functional changes.
Eyelid ptosis is the complication patients most fear and is worth explaining properly. It results from product reaching the muscle that elevates the upper eyelid, is uncommon with careful placement, and is temporary — typically settling over weeks as the effect wears off. Prescription eye drops can partially offset it in the meantime. Brow heaviness is a different and more common issue, usually from over-treating the forehead in someone who relies on that muscle to hold the brow up.
Upper-face studies generally find that most treatment-related complications are mild and transient, but anatomy and individualized planning remain important. Rare systemic spread of toxin effect is a recognized safety concern with botulinum toxin products and requires urgent medical attention if symptoms such as significant swallowing, speech or breathing difficulty develop.
Aftercare is simple and mostly about avoiding displacement in the first hours: stay upright for around four hours, avoid rubbing or massaging the treated area, and defer strenuous exercise, saunas and facial treatments until the next day.
Seek prompt medical advice for significant difficulty swallowing or breathing, generalized weakness, severe allergic symptoms, marked visual symptoms or any rapidly progressive neurological complaint after treatment.
Who may not be suitable?
Treatment may need to be postponed or avoided in people who are pregnant or breastfeeding, have active infection at the injection site, known hypersensitivity to a product component, certain neuromuscular disorders, or medical circumstances that increase the risk of excessive weakness or interaction. Medication history matters, including drugs that can affect neuromuscular transmission.
Neuromuscular conditions such as myasthenia gravis and related disorders deserve specific mention, as does aminoglycoside antibiotic use, because both can amplify the weakening effect. Declare any neurological diagnosis rather than assuming it is irrelevant to a cosmetic treatment.
A consultation should also identify pre-existing eyelid or brow ptosis, facial asymmetry, dry-eye symptoms, previous facial surgery and baseline smile or chewing mechanics so these are not incorrectly attributed to the treatment later. Photographing these before treatment protects both patient and clinician.
Expectations matter as much as physiology. A patient who wants no visible movement at all, or who is chasing a specific result seen on someone else, is worth slowing down rather than treating immediately.
Frequently asked questions
Will my face look frozen?
Not necessarily. The degree of movement reduction depends on muscle selection, dose and the treatment goal. Conservative treatment aims to soften excessive activity while preserving appropriate expression.
Can botulinum toxin make my jaw smaller?
It can reduce prominence from enlarged masseter muscles, but it does not reduce jaw bone width or remove facial fat. Proper diagnosis of the lower-face shape is important.
How often do I need treatment?
There is no universal interval. Retreatment is based on return of clinically meaningful muscle activity, the treatment area, product characteristics and individual response.
Can I combine it with filler or energy treatments?
Sometimes, because each treatment addresses a different anatomical problem. Sequencing depends on the areas treated and the overall plan.
Does it prevent wrinkles permanently?
No. The effect is temporary. Repeated reduction in muscle activity may reduce repeated creasing, but ageing, photodamage and skin-quality changes continue.
How long before I see results?
Usually nothing for the first two or three days, gradual softening through the first week, and full effect by around two weeks. That is the point to judge the result and adjust any asymmetry.
Does it hurt?
The needles are very fine and treatment takes only minutes. Most patients describe brief stinging. Small raised bumps at each point settle within about an hour.
Why does one side look different after a week?
Partial onset is frequently uneven and settles as the full effect develops. This is why the review is at two weeks — adjusting at day four often means treating something that would have evened out anyway.
Can I lie down or exercise afterwards?
Stay upright for around four hours and avoid rubbing the area. Strenuous exercise, saunas and facial treatments are usually deferred until the following day.
Why are prices per unit so different between clinics?
Because units are product-specific and not equivalent between formulations. A low price per unit may reflect a product whose units are dosed differently, so comparing per-unit prices across clinics is meaningless without knowing which product is used.
Can I become resistant to it?
Uncommonly, yes. Repeated treatment can occasionally lead to neutralising antibodies and reduced response. Very frequent treatment and high cumulative doses are thought to increase that risk, which argues against topping up more often than needed.
What is the difference between dynamic and static lines?
Dynamic lines appear on movement and respond well to toxin. Static lines are visible at rest and are etched into the skin. Toxin softens the movement maintaining them but may not erase the crease itself.
Will my wrinkles be worse if I stop?
No. Movement and lines gradually return to where they would have been. They do not overshoot or worsen because you stopped.
Can it treat excessive sweating?
Yes. Underarm and palmar hyperhidrosis is an established use, since the same signalling pathway drives sweat glands. It is a medical indication with its own dosing.
What causes eyelid droop and how long does it last?
It results from product reaching the muscle that lifts the upper eyelid. It is uncommon with careful placement, temporary, and typically settles over weeks. Prescription drops can partially offset it meanwhile.
Can I have treatment before a wedding or event?
Yes, but allow at least two to three weeks so the effect is full and any adjustment can be made. Treating in the final week risks partial onset and visible asymmetry on the day.
Can I have it while pregnant or breastfeeding?
Elective aesthetic treatment is conventionally postponed during pregnancy and breastfeeding, because safety data are absent rather than reassuring.
At what age should I start?
There is no correct age. The reasonable trigger is a dynamic line that is beginning to persist at rest, not a birthday or a preventative impulse in skin with no line at all.
Is botulinum toxin treatment claimable under MediSave or insurance in Singapore?
Cosmetic treatment is generally not claimable. Where treatment is for a medical indication such as hyperhidrosis, the position may differ, so check directly with your insurer.
Where is Aquila Medical Center?
Aquila Medical Center is at 160 Robinson Road, #05-01 SBF Centre Medical Suites, Singapore 068914, in the Singapore CBD, a short walk from Tanjong Pagar, Shenton Way and Telok Ayer MRT stations.
Selected references
- Cosmetic botulinum toxin A injections to the upper face: systematic review and meta-analysis.
- Complications of cosmetic botulinum toxin A injections to the upper face: systematic review and meta-analysis.
- Safety and tolerability of onabotulinumtoxinA for upper facial lines: meta-analysis.
- Botulinum toxin for masseter muscle hypertrophy: systematic review and meta-analysis.
- Guidelines for botulinum neurotoxin injection for facial contouring.
- Efficacy of botulinum toxin in masseter muscle hypertrophy for lower face contouring.
- American Academy of Dermatology. Botulinum toxin therapy overview.
- American Society of Plastic Surgeons. Botulinum toxin patient information.
This page is educational and does not replace an individual assessment. Product selection, dosing, muscle selection and suitability depend on your anatomy and medical history. Results vary between individuals and no outcome can be guaranteed. Content reviewed by the medical team at Aquila Medical Center, Singapore. Last reviewed: 26 August 2026.
Doctor-led botulinum toxin assessment in Singapore
The appropriate plan depends on which muscle is causing the concern, how strongly it contracts, what surrounding muscles are doing and whether the desired change is compatible with normal facial or body function.
Aquila Medical Center is located at 160 Robinson Road, #05-01 SBF Centre Medical Suites, Singapore 068914, a short walk from Tanjong Pagar, Shenton Way and Telok Ayer MRT stations. Where the concern is volume, skin quality or tissue position rather than muscle activity, we will say so.